First Trust Advisors LP decreased its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 55.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 33,122 shares of the financial services provider's stock after selling 40,511 shares during the quarter. First Trust Advisors LP owned 0.08% of Trupanion worth $848,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in TRUP. Dimensional Fund Advisors LP grew its holdings in shares of Trupanion by 15.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 702,086 shares of the financial services provider's stock valued at $17,981,000 after purchasing an additional 95,064 shares during the last quarter. Parallel Advisors LLC lifted its stake in Trupanion by 1,831.9% in the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider's stock valued at $47,000 after purchasing an additional 1,722 shares during the last quarter. Illinois Municipal Retirement Fund boosted its position in Trupanion by 2.3% in the first quarter. Illinois Municipal Retirement Fund now owns 17,819 shares of the financial services provider's stock valued at $456,000 after buying an additional 406 shares in the last quarter. Fifth Third Bancorp grew its stake in shares of Trupanion by 2,911.1% during the first quarter. Fifth Third Bancorp now owns 7,588 shares of the financial services provider's stock worth $194,000 after buying an additional 7,336 shares during the last quarter. Finally, Inspire Investing LLC grew its stake in shares of Trupanion by 58.7% during the first quarter. Inspire Investing LLC now owns 20,034 shares of the financial services provider's stock worth $513,000 after buying an additional 7,410 shares during the last quarter.
Insider Transactions at Trupanion
In related news, EVP Steve Weinrauch sold 6,674 shares of Trupanion stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $22.00, for a total value of $146,828.00. Following the transaction, the executive vice president directly owned 78,062 shares of the company's stock, valued at $1,717,364. The trade was a 7.88% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Fawwad Qureshi sold 6,177 shares of the company's stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $22.18, for a total value of $137,005.86. Following the completion of the sale, the chief financial officer owned 2,081 shares in the company, valued at $46,156.58. The trade was a 74.80% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 17,807 shares of company stock worth $394,452 over the last ninety days. 5.58% of the stock is owned by insiders.
Trupanion Stock Up 7.7%
Shares of NASDAQ:TRUP opened at $29.06 on Tuesday. The firm has a market cap of $1.27 billion, a P/E ratio of 54.83, a P/E/G ratio of 1.98 and a beta of 1.39. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24. Trupanion, Inc. has a 12-month low of $21.16 and a 12-month high of $51.78. The business has a fifty day simple moving average of $24.85 and a 200 day simple moving average of $26.11.
Trupanion (NASDAQ:TRUP - Get Free Report) last announced its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 EPS for the quarter, topping the consensus estimate of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The firm had revenue of $392.93 million for the quarter, compared to the consensus estimate of $389.72 million. During the same period in the previous year, the business earned $0.22 EPS. The business's quarterly revenue was up 11.1% compared to the same quarter last year. Analysts predict that Trupanion, Inc. will post 0.58 earnings per share for the current year.
Analysts Set New Price Targets
A number of brokerages have recently commented on TRUP. Stifel Nicolaus set a $28.00 price target on Trupanion in a research note on Friday, June 26th. Weiss Ratings restated a "sell (d+)" rating on shares of Trupanion in a research report on Monday, June 1st. Bank of America lowered their target price on Trupanion from $63.00 to $59.00 and set a "buy" rating for the company in a report on Tuesday, April 14th. Atlantic Securities set a $42.00 target price on Trupanion in a research report on Wednesday, July 15th. Finally, Zacks Research raised Trupanion from a "hold" rating to a "strong-buy" rating in a research note on Friday, July 24th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $41.60.
Get Our Latest Analysis on Trupanion
Trupanion Company Profile
(
Free Report)
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company's core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.